Recent advances. Cardiology

British Medical Journal

Volumn 316, Issue 7135, 1998, Pages 911-915

  Teo, Koon K ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN II ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN RECEPTOR ANTAGONIST;

CARDIOLOGY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DILATATION; DEFIBRILLATOR; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; SHORT SURVEY; SUDDEN DEATH;

EID: 0032554541     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7135.911     Document Type: Short Survey

References (15)

1. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Eng J Med 1995;332:1553-8.
2. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med 1994;330:956-61.
3. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, et al on behalf of the EPIC Investigators. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis:results at six months, Lancet 1994:343:881-6.
4. The CAPTURE Investigators. Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina, the CAPTURE study. Lancet 1997;349:1429-35.
5. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997:336:1689-96.
6. Moliterno DJ, Harrington RA, Califf RM, Rapold HJ, Topol EJ, for the PARADIGM Investigators. Randomized, placebo-controlled study of lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: rationale and design for the platelet aggregation receptor antagonist dose investigation and reperfusion gain in myocardial infarction (PARADIGM) study. J Thromb Thrombolysis 1995;2:165-9.
7. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Cheseboro JH. Insights into the pathogenesis of acute ischacmic syndromes. Circulation 1988:77:1213-20.
8. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation 1994;90:1631-7.
9. Antman EM, for the TIMI 9A Investigators. Hirudin in acute myocardial infarction. Safely report from the thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9A trial. Circulation 1994:90:1624-30.
10. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996;335:775-82.
11. Organization to Assess Strategies for Ischaemic Syndromes (OASIS) Investigators. Comparison of the effects of two doses of recombinant hirudin compared to heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Circulation (in press).
12. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995;91:476-85.
13. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J. et al for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
14. Zjistra F, De Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328:680-4.
15. Goy JJ, Eeckhout E, Stauffer JC, Vogt P, Kappenberger L. Emergency endoluminal stenting for abrupt vessel closure following coronary angioplasty: a randomized comparison of the Wiktor and Palmaz-Schatz stents. Catheter Cardiovasc Diag 1995;34:128-32.